Two-tier Lyme testing begins with a crucial distinction: a positive Lyme screening test is not, by itself, a positive Lyme test. That distinction matters when syphilis is in the differential, because antibodies produced against Treponema pallidum can react with antigens used in some Lyme disease screening assays. Treating the screen as a diagnosis can lead a clinician to label a patient with syphilis as having Lyme disease.
CEHF’s “Morgellons Arthritis” Article Does Not Say What Its Sources Say
A closer reading of CEHF’s citations reveals a four-day mouse experiment described as months of joint swelling, an animal study blurred into a human PTLDS diagnosis, and a 6 percent figure whose denominator changes as it moves through the Morgellons literature.
On August 13, 2026, the Charles E. Holman Morgellons Disease Foundation published an official statement warning Morgellons patients about unnamed critics whom it accused of failing to engage properly with peer-reviewed literature and of “nitpicking” researchers. The Foundation urged patients to rely on credible sources and peer-reviewed information while presenting its own work as rooted in scientific integrity.
That is a reasonable standard, and it should apply equally to CEHF. A standing article on the Foundation’s website, Understanding Morgellons Arthritis (archived May 18, 2026), provides an unusually useful test because its claims are specific and its scientific citations can be traced back to the original studies. The article, bylined to Mark Wilcox, was published in December 2022 and last modified February 20, 2023.
Morgellons Fibers After Twenty Years: Reading the New Middelveen–Stricker Review
A new review finally puts two decades of unpublished fiber data into the citable record. What it puts on the record — and how the publicity around it departs from the paper itself — deserves a careful read.
On July 31, 2026, Archives of Clinical and Biomedical Research published “The Cellular Origin of Morgellons Disease Fibers: A Twenty Year Odyssey” (Middelveen, Fesler, Stricker; ACBR 10(4):224–236, DOI 10.26502/acbr.50170529). It is a narrative review — the authors retracing the fiber-analysis literature from the 2004 Charles E. Holman Foundation fiber study through their own 2020 work — and it arrives with a stated mission: to consolidate the case that Morgellons fibers are human in origin, composed of keratin and collagen, produced by keratinocytes and fibroblasts, and in some cases identifiable as unusually small human hairs.
The Closed Loop: When Lyme Advocacy Stops Questioning Itself
The Lyme disease community was built, in large part, by people willing to question authority. That history makes the possibility of a Lyme disease echo chamber particularly uncomfortable to discuss. Patients challenged physicians who dismissed symptoms that did not fit established diagnostic categories. Advocates questioned testing standards they believed were inadequate, while researchers pushed against assumptions about diagnosis, treatment, persistence, and coinfections. That willingness to challenge prevailing ideas has often been one of the community’s greatest strengths. It forced difficult conversations and created space for patients who felt abandoned by conventional medicine.
But skepticism only has value when we apply it consistently. A community that demands scrutiny of government agencies, professional societies, insurance companies, and academic medicine should also scrutinize its own physicians, researchers, laboratories, advocacy organizations, websites, podcasts, and influential personalities. We cannot insist that outside institutions tolerate uncomfortable questions while treating the same questions differently when they point inward. Skepticism stops functioning as a method when it depends on who receives it.
Lyme Has Warriors. Syphilis Has Silence.
Lyme disease and syphilis occupy very different public worlds. With Lyme disease, a patient can enter an entire network of advocacy organizations, support groups, podcasts, documentaries, physician directories, disease-specific news outlets, awareness campaigns and fundraising galas. Global Lyme Alliance operates peer-support programs and holds a major annual gala, while LymeDisease.org maintains support groups, patient resources, physician information, research programs and multiple news and commentary publications. The Lyme community may be divided and controversial, but it is visible.[1][2]